TREA

90138790 - AEGLEA

Follow

Information

  • Trademark
  • 90138790
  • Serial Number
    90138790
  • Filing Date
    August 26, 2020
    4 years ago
  • Transaction Date
    August 17, 2024
    4 months ago
  • Status Date
    June 03, 2024
    6 months ago
  • Published for Opposition Date
    September 07, 2021
    3 years ago
  • Location Date
    November 02, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    ASKEW, MEGAN RUTH
  • Attorney Docket Number
    ABIO006US
    Attorney Name
    Christopher M. Kindel
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AEGLEA
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; pharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of cancer; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of cancer; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of cancer; enzyme replacement therapy preparations for medical purposes; pharmaceutical preparations for the prevention and treatment of infectious diseases and immunological diseases; biopharmaceutical preparations for the prevention and treatment of infectious diseases and immunological diseases; pharmaceutical preparations for the treatment of homocystinuria; biopharmaceutical preparations for the treatment of homocystinuria; biotherapeutic preparations for the treatment of homocystinuria
  • GS0421: Scientific research in the fields of pharmaceuticals, biopharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, enzyme replacement therapeutics, and therapeutics, all for the treatment of rare genetic diseases, Arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; medical and scientific research in the field of pharmaceutical and biopharmaceutical treatment of rare genetic diseases, Arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; providing medical and scientific research information, consultancy, and advisory services, all in the fields of pharmaceuticals, biopharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, enzyme replacement therapeutics, and therapeutics treatments, and all for the treatment of rare genetic diseases, Arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; Design, engineering, research, development and testing services, all for medical research purposes in the fields of cancer, rare genetic disease, Arginase 1 deficiency treatments, immunological diseases, homocystinuria, and infectious diseases
Case File Event Statements
  • 8/29/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/29/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/24/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/30/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/31/2020 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/31/2020 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/31/2020 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/29/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/29/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/31/2021 - 3 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/7/2021 - 3 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/18/2021 - 3 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/7/2021 - 3 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/2/2021 - 3 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/29/2022 - 2 years ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/29/2022 - 2 years ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/29/2022 - 2 years ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/1/2022 - 2 years ago
    21 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 5/3/2022 - 2 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/1/2022 - 2 years ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/1/2022 - 2 years ago
    20 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/3/2022 - 2 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/1/2023 - a year ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/2/2023 - a year ago
    28 - SOU EXTENSION 4 FILED Type: EXT4
  • 5/1/2023 - a year ago
    24 - SOU EXTENSION 3 FILED Type: EXT3
  • 5/1/2023 - a year ago
    25 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 5/3/2023 - a year ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/2/2023 - a year ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/2/2023 - a year ago
    29 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 11/4/2023 - a year ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/3/2024 - 6 months ago
    32 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 5/16/2024 - 7 months ago
    31 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/12/2024 - 5 months ago
    33 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6